(Q34398673)

1 August 2017

1 reference

title

T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis (English)

1 reference

experimental autoimmune encephalomyelitis

1 August 2017

0 references

0 references

1 reference

Iglesias A

1

1 reference

1 August 2017

Bauer J

2

1 reference

1 August 2017

Litzenburger T

3

1 reference

1 August 2017

Schubart A

4

1 reference

1 August 2017

Linington C

5

1 reference

1 August 2017

publication date

1 November 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

36

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

220-234

1 reference

Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis

1 August 2017

cites work

1 reference

Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG).

21 January 2018

1 reference

Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule

21 January 2018

1 reference

Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats

21 January 2018

1 reference

Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide.

21 January 2018

1 reference

Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen

21 January 2018

1 reference

IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis

21 January 2018

1 reference

Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily.

21 January 2018

1 reference

In healthy primates, circulating autoreactive T cells mediate autoimmune disease

21 January 2018

1 reference

Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

21 January 2018

1 reference

Late complications of immune deviation therapy in a nonhuman primate

21 January 2018

1 reference

Identification of autoantibodies associated with myelin damage in multiple sclerosis

21 January 2018

1 reference

Structure and evolution of the extended B7 family

21 January 2018

1 reference

Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives

21 January 2018

1 reference

Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination

21 January 2018

1 reference

The central nervous system-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS).

21 January 2018

1 reference

Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein

21 January 2018

1 reference

Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells.

21 January 2018

1 reference

Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia.

21 January 2018

1 reference

Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions.

21 January 2018

1 reference

High-dose soluble antigen: peripheral T-cell proliferation or apoptosis

21 January 2018

1 reference

Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein.

21 January 2018

1 reference

A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody

21 January 2018

1 reference

Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG).

21 January 2018

1 reference

T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.

21 January 2018

1 reference

B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice

21 January 2018

1 reference

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

21 January 2018

1 reference

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice.

21 January 2018

1 reference

Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis

21 January 2018

1 reference

A review of the molecular and cellular biology of butyrophilin, the major protein of bovine milk fat globule membrane

21 January 2018

1 reference

Genetics of rat neuroinflammation.

21 January 2018

1 reference

IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein

21 January 2018

1 reference

Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex

21 January 2018

1 reference

Physical mapping of the human and mouse MOG gene at the distal end of the MHC class Ib region

21 January 2018

1 reference

Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation

21 January 2018

1 reference

Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation

21 January 2018

1 reference

Cloning, expression analysis, and chromosomal localization of a novel butyrophilin-like receptor

21 January 2018

1 reference

BTL-II: a polymorphic locus with homology to the butyrophilin gene family, located at the border of the major histocompatibility complex class II and class III regions in human and mouse.

21 January 2018

1 reference

Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.

21 January 2018

1 reference

Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology.

21 January 2018

1 reference

Autoimmune demyelination in the central nervous system

21 January 2018

1 reference

Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system

21 January 2018

1 reference

Encephalitogenic and neuritogenic T cell responses to the myelin-associated glycoprotein (MAG) in the Lewis rat.

21 January 2018

1 reference

MHC haplotype-dependent regulation of MOG-induced EAE in rats.

21 January 2018

1 reference

Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement

21 January 2018

1 reference

The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls

21 January 2018

1 reference

Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study

21 January 2018

1 reference

Screening of several H-2 congenic mouse strains identified H-2q mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement

21 January 2018

1 reference

7 January 2021

The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat

1 reference

7 January 2021

Transgenic models of TNF induced demyelination

1 reference

7 January 2021

Myelin oligodendrocyte glycoprotein-DNA vaccination induces antibody-mediated autoaggression in experimental autoimmune encephalomyelitis

1 reference

7 January 2021

Linkage Analysis of Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis in the Rat Identifies a Locus Controlling Demyelination on Chromosome 18

1 reference

7 January 2021

Membrane topology of the myelin/oligodendrocyte glycoprotein

1 reference

7 January 2021

Antibodies to myelin/oligodendrocyte-specific protein and myelin/oligodendrocyte glycoprotein signal distinct changes in the organization of cultured oligodendroglial membrane sheets

1 reference

7 January 2021

Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1

1 reference

7 January 2021

Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis

1 reference

7 January 2021

Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes

1 reference

7 January 2021

Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions

1 reference

7 January 2021

Rhesus monkeys are highly susceptible to experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein: characterisation of immunodominant T- and B-cell epitopes

1 reference

7 January 2021

Investigation of myelin/oligodendrocyte glycoprotein membrane topology

1 reference

7 January 2021

Mapping of H2-M homolog and MOG genes in the rat MHC

1 reference

7 January 2021

The role of complement in the pathogenesis of experimental allergic encephalomyelitis

1 reference

7 January 2021

Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein

1 reference

7 January 2021

B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide

1 reference

7 January 2021

A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells

1 reference

7 January 2021

Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin.

1 reference

7 January 2021

A new primate model for multiple sclerosis in the common marmoset

1 reference

7 January 2021

Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains

1 reference

7 January 2021

Interferon-γ potentiates antibody-mediated demyelination in vivo

1 reference

7 January 2021

Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis

1 reference

7 January 2021

Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls

1 reference

7 January 2021

Identifiers

DOI

10.1002/GLIA.1111

1 reference

1 August 2017

1 reference